Home
>
National Drug Code (NDC)
>
Lodine
Lodine - 63629-1376-8 - (etodolac)
Drug Information of Lodine
| Product NDC: | 63629-1376 |
| Proprietary Name: | Lodine |
| Non Proprietary Name: | etodolac |
| Active Ingredient(s): | 300 mg/1 & nbsp; etodolac |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, GELATIN COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lodine
| Product NDC: | 63629-1376 |
| Labeler Name: | bryant ranch prepack |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075126 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090630 |
Package Information of Lodine
| Package NDC: | 63629-1376-8 |
| Package Description: | 25 CAPSULE, GELATIN COATED in 1 BOTTLE (63629-1376-8) |
NDC Information of Lodine
| NDC Code | 63629-1376-8 |
| Proprietary Name | Lodine |
| Package Description | 25 CAPSULE, GELATIN COATED in 1 BOTTLE (63629-1376-8) |
| Product NDC | 63629-1376 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | etodolac |
| Dosage Form Name | CAPSULE, GELATIN COATED |
| Route Name | ORAL |
| Start Marketing Date | 20090630 |
| Marketing Category Name | ANDA |
| Labeler Name | bryant ranch prepack |
| Substance Name | ETODOLAC |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
